Home › Funds › ACT Capital Partners, L.P. › PVLA
ACT Capital Partners, L.P. position in PVLA
PALVELLA THERAPEUTICS INC NE · Health Care
ACT Capital Partners, L.P. reported holding 22,500 shares of PVLA (PALVELLA THERAPEUTICS INC NE) in its Q3 2026 13F filing — a position valued at US$3.1M, representing 2.11% of its reported portfolio and ranking #14 among its reported holdings. ACT Capital Partners, L.P. first reported this position in Q3 2026.
Last updated: 2026-11-07 · Source: SEC EDGAR Form 13F-HR
How ACT Capital Partners, L.P.'s PVLA position evolved
ACT Capital Partners, L.P. first disclosed a stake in PVLA in Q3 2026 at 22,500 shares (US$3.1M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 22.50K | $3.10M | New |
About PVLA and 13F data
PVLA (PALVELLA THERAPEUTICS INC NE) is a Health Care company. 90 other funds we track also report a position in PVLA — the largest reported positions include MONTANOVA CAPITAL, LLC (US$173.5M), Frazier Life Sciences Management, L.P. (US$134.8M), First Light Asset Management, LLC (US$118.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PVLA
- MONTANOVA CAPITAL, LLC 1.14M sh · $173.51M · Q2 2026
- Frazier Life Sciences Management, L.P. 882.40K sh · $134.85M · Q2 2026
- First Light Asset Management, LLC 771.90K sh · $117.96M · Q2 2026
- BVF INC/IL 672.79K sh · $102.82M · Q2 2026
- FRONTIER CAPITAL MANAGEMENT CO LLC 478.83K sh · $73.18M · Q2 2026
- Siren, L.L.C. 257.49K sh · $39.35M · Q2 2026
- EMERALD ADVISERS, LLC 229.49K sh · $35.07M · Q2 2026
- MPM BioImpact LLC 204.03K sh · $31.18M · Q2 2026
- First Turn Management, LLC 156.45K sh · $23.91M · Q2 2026
- Bellevue Group AG 155.00K sh · $23.69M · Q2 2026
- NEXTBio Capital Management LP 89.91K sh · $13.74M · Q2 2026
- Clio Asset Management LLC 86.01K sh · $11.86M · Q3 2026
More on ACT Capital Partners, L.P.
FAQ
How long has ACT Capital Partners, L.P. held PVLA?
ACT Capital Partners, L.P. has disclosed PVLA holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is ACT Capital Partners, L.P.'s current position in PVLA?
As of Q3 2026, ACT Capital Partners, L.P. holds 22.50K shares of PVLA (PALVELLA THERAPEUTICS INC NE), valued at $3.10M, representing 2.11% of its reported portfolio and ranking #14.
Has ACT Capital Partners, L.P. been buying or selling PVLA?
In the latest 13F filing (Q3 2026), ACT Capital Partners, L.P. newly opened its position in PVLA.
Which other funds hold PVLA?
Other major institutional holders of PVLA include MONTANOVA CAPITAL, LLC, Frazier Life Sciences Management, L.P., First Light Asset Management, LLC, among 90 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.